Suppr超能文献

染色体倒位携带者真的需要进行胚胎植入前遗传学检测吗?

Do chromosomal inversion carriers really need preimplantation genetic testing?

机构信息

Center for Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200135, China.

Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, 200135, China.

出版信息

J Assist Reprod Genet. 2022 Nov;39(11):2573-2579. doi: 10.1007/s10815-022-02654-2. Epub 2022 Nov 11.

Abstract

PURPOSE

This study aimed to evaluate the rates of euploidy, aneuploidy, and mosaicism in preimplantation genetic testing for structural rearrangements (PGT-SR) cycles from chromosomal inversion carriers. In addition, this work also focused on assessing the impact of some contributors on the incidence of parental originating aneuploidy and mosaicism.

METHODS

This retrospective review enrolled chromosomal inversion carrier couples of whom the females were under 38 years old undergoing PGT-SR at a single academic reproductive center. Subgroups were divided according to the gender of carriers, the inversion type, and the semen parameters of male carriers (male factor infertility (MF) or non-MF). Patient demographics, cycle characteristics, and PGT-SR outcomes were compared among subgroups.

RESULTS

A total of 71 PGT-SR cycles from 57 inversion carrier couples were included for analysis. Among the 283 blastocysts, 48.4% were identified as euploidy, 27.9% as aneuploidy, and the remaining 23.7% as mosaicism. Only 32.9% of aneuploid embryos and 1.5% of mosaic embryos involved the parental inversion chromosomes. Notably, the female inversion carriers seemed to produce more parental originating aneuploid embryos than male inversion carriers (45.5% vs 23.9%, p = 0.044).

CONCLUSIONS

The type of inversion and sperm parameters of male chromosomal inversion carriers did not affect the ploidy status of embryos. The incidence of parental originating aneuploidy in inversion carrier couples is lower than expected. For male chromosomal inversion carriers with normal sperm condition whose female partners are under 38 years old, natural conception combined with prenatal diagnosis could be provided as an option during fertility counseling.

摘要

目的

本研究旨在评估染色体倒位携带者行胚胎植入前遗传学检测结构重排(PGT-SR)周期中的整倍体率、非整倍体率和嵌合体率。此外,本研究还重点评估了一些因素对亲源性非整倍体和嵌合体发生率的影响。

方法

本回顾性研究纳入了在一家学术生殖中心行 PGT-SR 的染色体倒位携带者夫妇,女性年龄均小于 38 岁。根据携带者的性别、倒位类型以及男性携带者的精液参数(男性因素不孕(MF)或非 MF)对亚组进行分组。比较了亚组间患者的人口统计学特征、周期特征和 PGT-SR 结果。

结果

共纳入 57 对染色体倒位携带者的 71 个 PGT-SR 周期进行分析。在 283 个囊胚中,48.4%为整倍体,27.9%为非整倍体,其余 23.7%为嵌合体。只有 32.9%的非整倍体胚胎和 1.5%的嵌合体胚胎涉及亲本倒位染色体。值得注意的是,女性倒位携带者似乎比男性倒位携带者产生更多的亲源性非整倍体胚胎(45.5% vs. 23.9%,p=0.044)。

结论

倒位类型和男性染色体倒位携带者的精子参数均不影响胚胎的倍性状态。倒位携带者夫妇中亲源性非整倍体的发生率低于预期。对于精子正常且女性年龄小于 38 岁的男性染色体倒位携带者,在生育咨询时可提供自然妊娠结合产前诊断作为一种选择。

相似文献

1
Do chromosomal inversion carriers really need preimplantation genetic testing?
J Assist Reprod Genet. 2022 Nov;39(11):2573-2579. doi: 10.1007/s10815-022-02654-2. Epub 2022 Nov 11.
3
Chromosomal analysis for embryos from balanced chromosomal rearrangement carriers using next generation sequencing.
Mol Reprod Dev. 2021 May;88(5):362-370. doi: 10.1002/mrd.23469. Epub 2021 Mar 29.
4
Non-invasive preimplantation genetic testing for putative mosaic blastocysts: a pilot study.
Hum Reprod. 2021 Jun 18;36(7):2020-2034. doi: 10.1093/humrep/deab080.
6
Male factor infertility impacts the rate of mosaic blastocysts in cycles of preimplantation genetic testing for aneuploidy.
J Assist Reprod Genet. 2019 Oct;36(10):2047-2055. doi: 10.1007/s10815-019-01584-w. Epub 2019 Oct 19.
9
Assessment of aneuploidy concordance between clinical trophectoderm biopsy and blastocyst.
Hum Reprod. 2019 Jan 1;34(1):181-192. doi: 10.1093/humrep/dey327.

引用本文的文献

1
Preimplantation genetic testing might not be the necessity for male patients with 47,XYY syndrome: A pilot study.
Reprod Med Biol. 2025 Apr 22;24(1):e12650. doi: 10.1002/rmb2.12650. eCollection 2025 Jan-Dec.
2
Fertility problems in men carrying chromosome 7 inversion: A retrospective, observational study.
Medicine (Baltimore). 2025 Jan 17;104(3):e41358. doi: 10.1097/MD.0000000000041358.

本文引用的文献

1
PGDIS position statement on the transfer of mosaic embryos 2021.
Reprod Biomed Online. 2022 Jul;45(1):19-25. doi: 10.1016/j.rbmo.2022.03.013. Epub 2022 Mar 20.
2
Comparison of day 5 blastocyst with day 6 blastocyst: Evidence from NGS-based PGT-A results.
J Assist Reprod Genet. 2022 Feb;39(2):369-377. doi: 10.1007/s10815-022-02397-0. Epub 2022 Jan 10.
3
Effect of parental origin and predictors for obtaining a euploid embryo in balanced translocation carriers.
Reprod Biomed Online. 2022 Jan;44(1):72-79. doi: 10.1016/j.rbmo.2021.09.007. Epub 2021 Sep 21.
5
The mechanisms and clinical application of mosaicism in preimplantation embryos.
J Assist Reprod Genet. 2020 Mar;37(3):497-508. doi: 10.1007/s10815-019-01656-x. Epub 2019 Dec 14.
8
Role of aneuploidy screening in preimplantation genetic testing for monogenic diseases in young women.
Fertil Steril. 2019 May;111(5):928-935. doi: 10.1016/j.fertnstert.2019.01.017. Epub 2019 Mar 25.
9
Infertility patients with chromosome inversions are not susceptible to an inter-chromosomal effect.
J Assist Reprod Genet. 2019 Mar;36(3):509-516. doi: 10.1007/s10815-018-1376-1. Epub 2018 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验